Thanks, Andy and good morning, everyone. I'd like to start by reviewing our consolidated financial results and bridges for the third quarter of 2024. Please note that the non-GAAP numbers I refer to are on an adjusted basis, excluding the Graphic Arts business and excluding the legal recoveries or expenses from 2024 and 2023 comparisons. Now let's turn to Slide 5. In the third quarter, we delivered impressive results. Sales were $91.4 million and gross profit was $20.7 million, resulting in a gross margin of 22.6%, reflecting lower input costs and a favorable sales mix. Our adjusted EBITDA came in at $13.5 million with margins of 14.8%, showing a sequential improvement of 150 basis points. Adjusted earnings per share rose to $0.27, up 35% year-over-year, highlighting our improved profitability, driven by both the restructuring initiatives and effective cost management. Cash flow from operations remained robust at $12.8 million and our free cash flow totaled $9.3 million, demonstrating our disciplined approach to capital management. We ended the quarter with net debt reduced to $66 million, further strengthening our balance sheet with leverage improving to approximately 1.3 times, excluding Graphic Arts. Looking at the sales bridge, our revenue for the third quarter was $91.4 million, compared to $90.3 million in the same period last year. This increase is primarily driven by a $1.6 million foreign exchange tailwind and a $0.3 million net contribution from price adjustments. Note that we continue to benefit from increases in Gas Cylinders, largely offset by pricing reductions in our Elektron segment as we pass through lower input costs. We also experienced a $0.8 million impact from lower volumes with improvements in Elektron, offset by declines in Gas Cylinders. Now turning to the profit bridge, our third quarter adjusted EBITDA was $13.5 million, up from $11 million in Q3 of last year. This improvement included a $1.5 million boost from net deflation, primarily related to lower magnesium costs. We also benefited from improved volume mix and the positive impact of price adjustments. Given the relatively modest increase in sales, we were especially pleased by the significant improvement in our adjusted EBITDA margin, which rose by 260 basis points over the prior year, adding approximately $2.5 million to our bottom-line. Now let's turn to Slide 6 for a detailed review of Elektron's third quarter financial results. In the third quarter, Elektron delivered a strong rebound in revenues and continued improvements in profitability. Sales were $48.8 million, up 7% year-over-year and 16.2% sequentially. This reflected a strong recovery in defense sales, although also pull forward by some customers in anticipation of both the port strikes and the hurricane season. Adjusted EBITDA was $8.9 million with a margin of 18.2%, reflecting year-over-year gains supported by favorable pricing and operational improvements. This marks our third consecutive quarter of margin growth, demonstrating ongoing efficiency gains. Demand was particularly strong in Defense, First Response and Healthcare with notable contributions from magnesium powders and Meals Ready-to-Eat markets. Transportation markets benefited from stronger RotaMag sales, offsetting weaker Auto Catalysis performance, while General Industrial segments appear to be in the early stages of a gradual recovery. Elektron's results underscore the success of our focus on efficiency, innovation and resilience. Now let's turn to Slide 7 for a detailed review of Gas Cylinders' third quarter financial results. Gas Cylinders performance for the quarter was resilient despite some headwinds. Sales were $42.6 million, reflecting a 4.7% decrease year-over-year, but demonstrating stability with more normal levels of SCBA sales. Indeed, year-to-date sales are up following strong SCBA performance in the first half. Adjusted EBITDA reached $4.6 million, representing a 64.3% year-over-year increase with margins of 10.8%. The 450 basis point margin improvement was primarily driven by the benefits of new long-term pricing contracts established at the end of 2023, as well as tailwinds from the partial closure of the Pomona, California operation. In terms of market performance, the Defense, First Response and Healthcare segment experienced lower sales in the quarter due to the timing of SCBA projects, though Healthcare demand remained steady. We also saw encouraging signs of growth in the European industrial markets, driving stronger demand for our cylinders. Transportation, while slower than initially anticipated in the quarter, remained steady on a year-to-date basis. Overall, the Gas Cylinders segment is showing stability and year-to-date is benefiting considerably from the new long-term pricing agreements, as well as from efficiency gains. We are confident that our strategic growth initiatives, especially in the area of clean energy, will drive long-term future revenue and profitability increases. Now please turn to Slide 8 for an update on our full year 2024 financial guidance. As a reminder, our 2024 guidance excludes the Graphic Arts business. This quarter, we've added an additional level of granularity by presenting guidance for adjusted EBITDA and adjusted diluted EPS, both with and without the impacts of nonrecurring legal cost recoveries, providing a clearer view of our core operations. Excluding legal cost recoveries, our increased guidance for adjusted EBITDA is now between $45 million and $47 million. Therefore, we increased our adjusted diluted EPS to a higher range of $0.88 to $0.94. Including legal cost recoveries, our outlook is even higher. We now anticipate adjusted EBITDA to be between $52 million and $54 million, with adjusted diluted EPS ranging from $1.09 to $1.14. Turning specifically to free cash flow. We expect it to be between $35 million and $37 million. Our updated free cash flow range includes the benefits from improved business performance, legal fee recoveries and the net proceeds from the Lakehurst, New Jersey land sale received in early October. So, with these sales proceeds and ongoing working capital improvements, we anticipate our net debt-to-EBITDA ratio will decrease to approximately 1.1 times. These improvements underline our ongoing commitment to maintaining a robust balance sheet and enhancing our free cash flow. This financial stability supports our strategic initiatives, allowing for thoughtful continued investments in growth opportunities, while also paying down debt and returning capital to shareholders. Now I'd like to turn the call back to Andy. Andy?